Table 1 Demographic and clinical characteristics of the sample
|  | Control (n = 53) | Schizophrenia (n = 69) | Bipolar (n = 16) |
|---|---|---|---|
Age: mean (SD) [minimum, maximum] | 19.5 (3.3) [13, 32] | 19.9 (3.5) [13, 30] | 21.4 (3.4) [14, 27] |
Gender (% male/female) | 64/36 | 88/12 | 75/25 |
Subject education: mean (SD) | 12.7 (2.9) | 12.0 (2.2) | 12.7 (1.7) |
Parental education: mean (SD) | 14.1 (3.2) | 13.9 (2.8) | 14.8 (2.6) |
SANS: mean (SD) | – | 10.3 (3.6) | 7.5 (4.9) |
SAPS: mean (SD) | – | 6.2 (3.7) | 2.9 (3.3) |
BPRS: mean (SD) | – | 42.04 (8.2) | 38.1 (8.0) |
GAF: mean (SD) | – | 41.46 (8.5) | 46.50 (13.0) |
WASI: mean (SD) | 115.71 (10.0) | 100.49 (13.2) | 100.13 (11.2) |
Duration of illness: mean number of days (SD) | – | 319.25 (243.0) | 226.00 (204.5) |
Antipsychotic dose (CPZ mg): mean (SD) | – | 252.1 (192.2) | 271.2 (202.7) |
Antipsychotic medication: (n) | – |  |  |
 Aripiprazole  Asenapine  Haloperidol  Olanzapine  Quetiapine  Risperidone  Ziprasidone  More than one atypical  Unmedicated |  | 14 1 1 7 3 27 1 5 10 | 1 0 0 2 1 5 1 1 5 |